A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention

被引：0
作者：
Sharma, SK
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 04期
关键词：
D O I：
10.1016/j.amjcard.2003.07.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：524 / 525
页数：2
相关论文
共 4 条
[1]   Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: A 30-day follow-up study [J].
Kaul, U ;
Gupta, RK ;
Haridas, KK ;
Ramesh, SS ;
Seth, KK ;
Singh, B ;
Agarwal, R ;
Yadave, RD ;
Ghose, T ;
Sapra, RR ;
Bajaj, R ;
Shahi, M ;
Bhagwat, A ;
Kumar, P ;
Mathews, OP .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 57 (04) :497-503
[2]   The dark side of platelet glycoprotein IIb/IIIa receptor inhibitors during percutaneous coronary interventions [J].
Klein, LW ;
Calvin, JE .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (10) :1199-1202
[3]   Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET [J].
Moliterno, DJ ;
Chan, AW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) :49S-54S
[4]   A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention [J].
Vakili, BA ;
Kaplan, RC ;
Slater, JN ;
Sherman, W ;
Ravi, KL ;
Green, SJ ;
Sanborn, T ;
Brown, DL .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (08) :946-950
1